Macrophages regulate the systemic response to DNA damage by a cell nonautonomous mechanism

Cancer Research

Volumn 75, Issue 13, 2015, Pages 2663-2673

  Geiger Maor, Anat ^a   Guedj, Avital ^a   Even Ram, Sharona ^a   Smith, Yoav ^b   Galun, Eithan ^a   Rachmilewitz, Jacob ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; DOUBLE STRANDED DNA; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CORRELATIONAL STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DNA END JOINING REPAIR; DOUBLE STRANDED DNA BREAK; DRUG EFFECTS; FIBROBLAST; IMMUNOLOGY; LIVER; MONOCYTE; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DNA END-JOINING REPAIR; ERBB RECEPTORS; FIBROBLASTS; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; HUMANS; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 84942636275     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-3635     Document Type: Article

References (51)

1. David SS, O'Shea VL, Kundu S. Base-excision repair of oxidative DNA damage. Nature 2007;447:941-50.
2. Redon CE, Dickey JS, Nakamura AJ, Kareva IG, Naf D, Nowsheen S, et al. Tumors induce complex DNA damage in distant proliferative tissues in vivo. Proc Natl Acad Sci U S A 2010;107:17992-7.
3. Dizdaroglu M, Rao G, Halliwell B, Gajewski E. Damagetothe DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions. Arch Biochem Biophys 1991;285:317-24.
4. Imlay JA, Chin SM, Linn S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 1988;240: 640-2.
5. Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001;477:7-21.
6. Behrend L, Henderson G, Zwacka RM. Reactiveoxygen speciesinoncogenic transformation. Biochem Soc Trans 2003;31:1441-4.
7. Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010;40:179-204.
8. Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, et al. GammaH2AX and cancer. Nat Rev Cancer 2008;8:957-67.
9. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858-68.
10. Shroff R, Arbel-Eden A, Pilch D, Ira G, Bonner WM, Petrini JH, et al. Distribution and dynamics of chromatin modification induced by a defined DNA double-strand break. Curr Biol 2004;14:1703-11.
11. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003;17:1195-214.
12. Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010;38:96-109.
13. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296:301-5.
14. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001;13:114-9.
15. Geiger-Maor A, Levi I, Even-Ram S, Smith Y, Bowdish DM, Nussbaum G, et al. Cells exposed to sublethal oxidative stress selectively attract monocytes/macrophages via scavenger receptors and MyD88-mediated signaling. J Immunol 2012;188:1234-44.
16. Breen AP, Murphy JA. Reactions of oxyl radicals with DNA. Free Radic Biol Med 1995;18:1033-77.
17. Konat GW. H2O2-induced higher order chromatin degradation: a novel mechanism of oxidative genotoxicity. J Biosci 2003;28:57-60.
18. Wang R, Lu M, Zhang J, Chen S, Luo X, Qin Y, et al. Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer. J Exp Clin Cancer Res 2011;30:62.
19. Qi Y, Chen X, Chan CY, Li D, Yuan C, Yu F, et al. Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma. Int J Cancer 2008;122:2682-8.
20. Santos NP, Pereira IC, Pires MJ, Lopes C, Andrade R, Oliveira MM, et al. Histology, bioenergetics and oxidative stress in mouse liver exposed to N-diethylnitrosamine. In Vivo 2012;26:921-9.
21. Paula Santos N, Colaco A, Gil da Costa RM, Manuel Oliveira M, Peixoto F, Alexandra Oliveira P. N-diethylnitrosamine mouse hepatotoxicity: time-related effects on histology and oxidative stress. Exp Toxicol Pathol 2014;66:429-36.
22. Bakiri L, Wagner EF. Mouse models for liver cancer. Mol Oncol 2013; 7:206-23.
23. Ivashkevich A, Redon CE, Nakamura AJ, Martin RF, Martin OA. Use of the gH2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Lett 2011;327:123-33.
24. Svetlova MP, Solovjeva LV, Tomilin NV. Mechanism of elimination of phosphorylated histone H2AX from chromatin after repair of DNA doublestrand breaks. Mutat Res 2010;685:54-60.
25. Kuo LJ, Yang LX. Gamma-H2AX - a novel biomarker for DNA doublestrand breaks. In Vivo 2008;22:305-9.
26. Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005;121:977-90.
27. Ljungman M. The DNA damage response-repair or despair? Environ Mol Mutagen 2010;51:879-89.
28. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009;461:1071-8.
29. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991;251:936-9.
30. Iwamoto R, Mekada E. Heparin-binding EGF-like growth factor: a juxta-crine growth factor. Cytokine Growth Factor Rev 2000;11:335-44.
31. Wang F, Liu R, Lee SW, Sloss CM, Couget J, Cusack JC. Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance. Oncogene 2007;26:2006-16.
32. Wang M, Morsbach F, Sander D, Gheorghiu L, Nanda A, Benes C, et al. EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks. Cancer Res 2011; 71:6261-9.
33. Kriegs M, Kasten-Pisula U, Rieckmann T, Holst K, Saker J, Dahm-Daphi J, et al. The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining. DNA Repair 2010;9:889-97.
34. Burdak-Rothkamm S, Rube CE, Nguyen TP, Ludwig D, Feldmann K, Wiegel T, et al. Radiosensitivity of tumor cell lines after pretreatment with the EGFR tyrosine kinase inhibitor ZD1839 (Iressa). Strahlenther Onkol 2005;181:197-204.
35. Mukherjee B, McEllin B, Camacho CV, Tomimatsu N, Sirasanagandala S, Nannepaga S, et al. EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. Cancer Res 2009;69:4252-9.
36. Collins AR. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 2004;26:249-61.
37. Collins AR. Investigating oxidative DNA damage and its repair using the comet assay. Mutat Res 2009;681:24-32.
38. Stucki M, Jackson SP. gammaH2AX and MDC1: anchoring the DNA-damage-response machinerytobroken chromosomes. DNARepair(Amst) 2006;5:534-43.
39. Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA doublestrand breaks. J Cell Biol 2000;151:1381-90.
40. Shahar OD, Raghu Ram EV, Shimshoni E, Hareli S, Meshorer E, Goldberg M. Live imaging of induced and controlled DNA double-strand break formation reveals extremely low repair by homologous recombination in human cells. Oncogene 2012;31:3495-504.
41. Kiso S, Kawata S, Tamura S, Higashiyama S, Ito N, Tsushima H, et al. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy. Hepatology 1995;22:1584-90.
42. Dateoka S, Ohnishi Y, Kakudo K. Effects of CRM197, a specific inhibitor of HB-EGF, in oral cancer. Med Mol Morphol 2012;45:91-7.
43. Tang X-h, Li M, Deng S, Lu M-s. Cross-reacting material 197, a heparinbinding EGF-like growth factor inhibitor, reverses the chemoresistance in human cisplatin-resistant ovarian cancer. Anticancer Drugs 2014;25: 1201-10.
44. Todorova MI, Larroque AL, Dauphin-Pierre S, Fang YQ, Jean-Claude BJ. Subcellular distribution of a fluorescence-labeled combi-molecule designed to block epidermal growth factor receptor tyrosine kinase and damage DNA with a green fluorescent species. Mol Cancer Ther 2010;9:869-82.
45. Banerjee R, Huang Y, Qiu Q, McNamee JP, Belinsky G, Jean-Claude BJ. The combi-targeting concept: mechanism of action of the pleiotropic combimolecule RB24 and discovery of a novel cell signaling-based combination principle. Cell Signal 2011;23:630-40.
46. Yacoub A, McKinstry R, Hinman D, Chung T, Dent P, Hagan MP. Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling. Radiat Res 2003;159: 439-52.
47. Yacoub A, Park JS, Qiao L, Dent P, Hagan MP. MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion. Int J Radiat Biol 2001;77:1067-78.
48. Boone JJ, Bhosle J, Tilby MJ, Hartley JA, Hochhauser D. Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents. Mol Cancer Ther 2009;8:3015-23.
49. Dittmann K, Mayer C, Kehlbach R, Rothmund MC, Peter Rodemann H. Radiation-induced lipid peroxidation activates src kinase and triggers nuclear EGFR transport. Radiother Oncol 2009;92:379-82.
50. Willimsky G, Czeh M, Loddenkemper C, Gellermann J, Schmidt K, Wust P, et al. Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. J Exp Med 2008; 205:1687-700.
51. Houthuijzen JM, Daenen LGM, Roodhart JML, Oosterom I, van Jaarsveld MTM, Govaert KM, et al. Lysophospholipids secreted by splenic macrophages induce chemotherapy resistance via interference with the DNA damage response. Nat Commun 2014;5:1-10.